| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E-mail contact: JoussenA{at}aol.com, tony.adamis{at}eyetk.com
Diabetic retinopathy is a leading cause of adult vision loss and blindness. Much of the retinal damage that characterizes the disease results from retinal vascular leakage and nonperfusion. Diabetic retinal vascular leakage, capillary nonperfusion, and endothelial cell damage are temporary and spatially associated with retinal leukocyte stasis in early experimental diabetes. Retinal leukostasis increases within days of developing diabetes and correlates with the increased expression of retinal intercellular adhesion molecule-1 (ICAM-1) and CD18. Mice deficient in the genes encoding for the leukocyte adhesion molecules CD18 and ICAM-1 were studied in two models of diabetic retinopathy with respect to the long-term development of retinal vascular lesions. CD18−/− and ICAM-1−/− mice demonstrate significantly fewer adherent leukocytes in the retinal vasculature at 11 and 15 months after induction of diabetes with STZ. This condition is associated with fewer damaged endothelial cells and lesser vascular leakage. Galactosemia of up to 24 months causes pericyte and endothelial cell loss and formation of acellular capillaries. These changes are significantly reduced in CD18- and ICAM-1-deficient mice. Basement membrane thickening of the retinal vessels is increased in long-term galactosemic animals independent of the genetic strain. Here we show that chronic, low-grade subclinical inflammation is responsible for many of the signature vascular lesions of diabetic retinopathy. These data highlight the central and causal role of adherent leukocytes in the pathogenesis of diabetic retinopathy. They also underscore the potential utility of anti-inflammatory treatment in diabetic retinopathy.
Key words: adhesion molecules • retina • vascular lesions
This article has been cited by other articles:
|
|
 |
|
  R. Talahalli, S. Zarini, N. Sheibani, R. C. Murphy, and R. A. Gubitosi-Klug Increased Synthesis of Leukotrienes in the Mouse Model of Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., March 1, 2010; 51(3): 1699 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chahed, A. S. Leroyer, M. Benzerroug, D. Gaucher, A. Georgescu, S. Picaud, J.-S. Silvestre, A. Gaudric, A. Tedgui, P. Massin, et al. Increased Vitreous Shedding of Microparticles in Proliferative Diabetic Retinopathy Stimulates Endothelial Proliferation Diabetes, March 1, 2010; 59(3): 694 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hirano, E. Sakurai, A. Matsubara, and Y. Ogura Suppression of ICAM-1 in Retinal and Choroidal Endothelial Cells by Plasmid Small-Interfering RNAs In Vivo Invest. Ophthalmol. Vis. Sci., January 1, 2010; 51(1): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Shen, R. S. Smith Jr., Y.-T. Hsu, L. Chao, and J. Chao Kruppel-like Factor 4 Is a Novel Mediator of Kallistatin in Inhibiting Endothelial Inflammation via Increased Endothelial Nitric-oxide Synthase Expression J. Biol. Chem., December 18, 2009; 284(51): 35471 - 35478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. Nguyen, R. Kawasaki, A. J. Kreis, J. J. Wang, J. Shaw, W. Vilser, and T. Y. Wong Correlation of Light-Flicker-Induced Retinal Vasodilation and Retinal Vascular Caliber Measurements in Diabetes Invest. Ophthalmol. Vis. Sci., December 1, 2009; 50(12): 5609 - 5613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, Y. Hu, T. Zhou, K. K. Zhou, R. Mott, M. Wu, M. Boulton, T. J. Lyons, G. Gao, and J.-x. Ma Activation of the Wnt Pathway Plays a Pathogenic Role in Diabetic Retinopathy in Humans and Animal Models Am. J. Pathol., December 1, 2009; 175(6): 2676 - 2685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Bhatwadekar, J. V. Glenn, T. M. Curtis, M. B. Grant, A. W. Stitt, and T. A. Gardiner Retinal Endothelial Cell Apoptosis Stimulates Recruitment of Endothelial Progenitor Cells Invest. Ophthalmol. Vis. Sci., October 1, 2009; 50(10): 4967 - 4973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Iliaki, V. Poulaki, N. Mitsiades, C. S. Mitsiades, J. W. Miller, and E. S. Gragoudas Role of {alpha}4 Integrin (CD49d) in the Pathogenesis of Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2009; 50(10): 4898 - 4904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Nguyen, E. Alibrahim, F.M. A. Islam, R. Klein, B. E.K. Klein, M. F. Cotch, S. Shea, and T. Y. Wong Inflammatory, Hemostatic, and Other Novel Biomarkers for Diabetic Retinopathy: The Multi-Ethnic Study of Atherosclerosis Diabetes Care, September 1, 2009; 32(9): 1704 - 1709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bucolo, K. W. Ward, E. Mazzon, S. Cuzzocrea, and F. Drago Protective Effects of a Coumarin Derivative in Diabetic Rats Invest. Ophthalmol. Vis. Sci., August 1, 2009; 50(8): 3846 - 3852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Park, Y. Chen, Y. Hu, A. S. Mayo, U. B. Kompella, R. Longeras, and J.-x. Ma Nanoparticle-Mediated Expression of an Angiogenic Inhibitor Ameliorates Ischemia-Induced Retinal Neovascularization and Diabetes-Induced Retinal Vascular Leakage Diabetes, August 1, 2009; 58(8): 1902 - 1913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kubota, T. Kurihara, H. Mochimaru, S. Satofuka, K. Noda, Y. Ozawa, Y. Oike, S. Ishida, and K. Tsubota Prevention of Ocular Inflammation in Endotoxin-Induced Uveitis with Resveratrol by Inhibiting Oxidative Damage and Nuclear Factor-{kappa}B Activation Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3512 - 3519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Satofuka, A. Ichihara, N. Nagai, K. Noda, Y. Ozawa, A. Fukamizu, K. Tsubota, H. Itoh, Y. Oike, and S. Ishida (Pro)renin Receptor-Mediated Signal Transduction and Tissue Renin-Angiotensin System Contribute to Diabetes-Induced Retinal Inflammation Diabetes, July 1, 2009; 58(7): 1625 - 1633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Roy, D. M. Hallman, Y.-P. Fu, M. Machado, and C. L. Hanis Assessment of 193 Candidate Genes for Retinopathy in African Americans With Type 1 Diabetes Arch Ophthalmol, May 1, 2009; 127(5): 605 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. K. Yego, J. A. Vincent, V. Sarthy, J. V. Busik, and S. Mohr Differential Regulation of High Glucose-Induced Glyceraldehyde-3-Phosphate Dehydrogenase Nuclear Accumulation in Muller Cells by IL-1{beta} and IL-6 Invest. Ophthalmol. Vis. Sci., April 1, 2009; 50(4): 1920 - 1928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sasaki, Y. Ozawa, T. Kurihara, K. Noda, Y. Imamura, S. Kobayashi, S. Ishida, and K. Tsubota Neuroprotective Effect of an Antioxidant, Lutein, during Retinal Inflammation Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1433 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tawfik, T. Sanders, K. Kahook, S. Akeel, A. Elmarakby, and M. Al-Shabrawey Suppression of Retinal Peroxisome Proliferator-Activated Receptor {gamma} in Experimental Diabetes and Oxygen-Induced Retinopathy: Role of NADPH Oxidase Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Brunner, G.-H. Schernthaner, M. Satler, M. Elhenicky, F. Hoellerl, K. E. Schmid-Kubista, F. Zeiler, S. Binder, and G. Schernthaner Correlation of Different Circulating Endothelial Progenitor Cells to Stages of Diabetic Retinopathy: First In Vivo Data Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 392 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kanwar and R. A. Kowluru Role of Glyceraldehyde 3-Phosphate Dehydrogenase in the Development and Progression of Diabetic Retinopathy Diabetes, January 1, 2009; 58(1): 227 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-A. C. Portillo, J. Van Grol, L. Zheng, G. Okenka, K. Gentil, A. Garland, E. C. Carlson, T. S. Kern, and C. S. Subauste CD40 Mediates Retinal Inflammation and Neurovascular Degeneration J. Immunol., December 15, 2008; 181(12): 8719 - 8726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sancho-Pelluz, K. A. Wunderlich, U. Rauch, F. J. Romero, T. van Veen, G. A. Limb, P. R. Crocker, and M.-T. Perez Sialoadhesin Expression in Intact Degenerating Retinas and Following Transplantation Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5602 - 5610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Wickremasinghe, S. L. Rogers, M. C. Gillies, M. Zhu, and T. Y. Wong Retinal Vascular Caliber Changes after Intravitreal Triamcinolone Treatment for Diabetic Macular Edema Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4707 - 4711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M A. El-Asrar, L Missotten, and K Geboes Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibrovascular epiretinal membranes Br J Ophthalmol, November 1, 2008; 92(11): 1534 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. X Zhang, J. J Wang, A. Dashti, K. Wilson, M.-H. Zou, L. Szweda, J.-X. Ma, and T. J Lyons Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein J. Mol. Endocrinol., September 1, 2008; 41(3): 135 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Al-Shabrawey, M. Rojas, T. Sanders, A. Behzadian, A. El-Remessy, M. Bartoli, A. K. Parpia, G. Liou, and R. B. Caldwell Role of NADPH Oxidase in Retinal Vascular Inflammation Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3239 - 3244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia-Ramirez, C. Hernandez, and R. Simo Expression of Erythropoietin and Its Receptor in the Human Retina: A comparative study of diabetic and nondiabetic subjects Diabetes Care, June 1, 2008; 31(6): 1189 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nehme and J. Edelman Dexamethasone Inhibits High Glucose-, TNF-{alpha}-, and IL-1{beta}-Induced Secretion of Inflammatory and Angiogenic Mediators from Retinal Microvascular Pericytes Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 2030 - 2038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Gubitosi-Klug, R. Talahalli, Y. Du, J. L. Nadler, and T. S. Kern 5-Lipoxygenase, but Not 12/15-Lipoxygenase, Contributes to Degeneration of Retinal Capillaries in a Mouse Model of Diabetic Retinopathy Diabetes, May 1, 2008; 57(5): 1387 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Saito, A. Uppal, G. Byfield, S. Budd, and M. E. Hartnett Activated NAD(P)H Oxidase from Supplemental Oxygen Induces Neovascularization Independent of VEGF in Retinopathy of Prematurity Model Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1591 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Kowluru, B. Menon, and D. L. Gierhart Beneficial Effect of Zeaxanthin on Retinal Metabolic Abnormalities in Diabetic Rats Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1645 - 1651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Giansanti, M. Ramazzotti, L. Vannozzi, E. Rapizzi, T. Fiore, B. Iaccheri, D. Degl' Innocenti, D. Moncini, and U. Menchini A Pilot Study on Ocular Safety of Intravitreal Infliximab in a Rabbit Model Invest. Ophthalmol. Vis. Sci., March 1, 2008; 49(3): 1151 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. Nguyen, J. J. Wang, A. R. Sharrett, F.M. A. Islam, R. Klein, B. E.K. Klein, M. F. Cotch, and T. Y. Wong Relationship of Retinal Vascular Caliber With Diabetes and Retinopathy: The Multi-Ethnic Study of Atherosclerosis (MESA) Diabetes Care, March 1, 2008; 31(3): 544 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Leal, A. Manivannan, K.-I. Hosoya, T. Terasaki, J. Cunha-Vaz, A. F. Ambrosio, and J. V. Forrester Inducible Nitric Oxide Synthase Isoform Is a Key Mediator of Leukostasis and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5257 - 5265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Walker and J. J. Steinle Role of {beta}-Adrenergic Receptors in Inflammatory Marker Expression in Muller Cells Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5276 - 5281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yao, T. Taguchi, T. Matsumura, R. Pestell, D. Edelstein, I. Giardino, G. Suske, N. Rabbani, P. J. Thornalley, V. P. Sarthy, et al. High Glucose Increases Angiopoietin-2 Transcription in Microvascular Endothelial Cells through Methylglyoxal Modification of mSin3A J. Biol. Chem., October 19, 2007; 282(42): 31038 - 31045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. T. Nguyen, J. J. Wang, and T. Y. Wong Retinal Vascular Changes in Pre-Diabetes and Prehypertension: New findings and their research and clinical implications Diabetes Care, October 1, 2007; 30(10): 2708 - 2715. [Full Text] [PDF]
|
|
|
|
|
|
J. Shen, B. Xie, A. Dong, M. Swaim, S. F. Hackett, and P. A. Campochiaro In Vivo Immunostaining Demonstrates Macrophages Associate with Growing and Regressing Vessels Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4335 - 4341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagai, K. Izumi-Nagai, Y. Oike, T. Koto, S. Satofuka, Y. Ozawa, K. Yamashiro, M. Inoue, K. Tsubota, K. Umezawa, et al. Suppression of Diabetes-Induced Retinal Inflammation by Blocking the Angiotensin II Type 1 Receptor or Its Downstream Nuclear Factor-{kappa}B Pathway Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4342 - 4350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Poulaki, E. Iliaki, N. Mitsiades, C. S. Mitsiades, Y. N. Paulus, D. V. Bula, E. S. Gragoudas, and J. W. Miller Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis FASEB J, July 1, 2007; 21(9): 2113 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M Abu El-Asrar, L. Missotten, and K. Geboes Expression of hypoxia-inducible factor-1{alpha} and the protein products of its target genes in diabetic fibrovascular epiretinal membranes Br J Ophthalmol, June 1, 2007; 91(6): 822 - 826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Shelton, T. S. Kern, and J. J. Mieyal Glutaredoxin Regulates Nuclear Factor {kappa}-B and Intercellular Adhesion Molecule in Muller Cells: MODEL OF DIABETIC RETINOPATHY J. Biol. Chem., April 27, 2007; 282(17): 12467 - 12474. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Caballero, N. Sengupta, A. Afzal, K.-H. Chang, S. Li Calzi, D. L. Guberski, T. S. Kern, and M. B. Grant Ischemic Vascular Damage Can Be Repaired by Healthy, but Not Diabetic, Endothelial Progenitor Cells Diabetes, April 1, 2007; 56(4): 960 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hafezi-Moghadam, K. L. Thomas, and D. D. Wagner ApoE deficiency leads to a progressive age-dependent blood-brain barrier leakage Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1256 - C1262. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Kern, C. M. Miller, Y. Du, L. Zheng, S. Mohr, S. L. Ball, M. Kim, J. A. Jamison, and D. P. Bingaman Topical Administration of Nepafenac Inhibits Diabetes-Induced Retinal Microvascular Disease and Underlying Abnormalities of Retinal Metabolism and Physiology Diabetes, February 1, 2007; 56(2): 373 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zheng, B. Gong, D. A. Hatala, and T. S. Kern Retinal Ischemia and Reperfusion Causes Capillary Degeneration: Similarities to Diabetes Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 361 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Satofuka, A. Ichihara, N. Nagai, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, H. Itoh, et al. Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 422 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Chidlow Jr., W. Langston, J. J.M. Greer, D. Ostanin, M. Abdelbaqi, J. Houghton, A. Senthilkumar, D. Shukla, A. P. Mazar, M. B. Grisham, et al. Differential Angiogenic Regulation of Experimental Colitis Am. J. Pathol., December 1, 2006; 169(6): 2014 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Hartnett, D. J. Martiniuk, Y. Saito, P. Geisen, L. J. Peterson, and J. R. McColm Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4975 - 4982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Muranaka, Y. Yanagi, Y. Tamaki, T. Usui, N. Kubota, A. Iriyama, Y. Terauchi, T. Kadowaki, and M. Araie Effects of Peroxisome Proliferator-Activated Receptor {gamma} and Its Ligand on Blood-Retinal Barrier in a Streptozotocin-Induced Diabetic Model. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4547 - 4552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. van Eeden, L. B. G. Tee, S. Lukehurst, C.-M. Lai, E. P. Rakoczy, L. D. Beazley, and S. A. Dunlop Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. Invest. Ophthalmol. Vis. Sci., October 1, 2006; 47(10): 4638 - 4645. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Goebel, M. Huang, W. C. Davis, M. Jennings, T. J. Siahaan, J. S. Alexander, and C. G. Kevil VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G648 - G654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Amrite, S. P. Ayalasomayajula, N. P. S. Cheruvu, and U. B. Kompella Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE2, VEGF, and Vascular Leakage. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 1149 - 1160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Navarro and C. Mora Role of inflammation in diabetic complications Nephrol. Dial. Transplant., December 1, 2005; 20(12): 2601 - 2604. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Feit-Leichman, R. Kinouchi, M. Takeda, Z. Fan, S. Mohr, T. S. Kern, and D. F. Chen Vascular Damage in a Mouse Model of Diabetic Retinopathy: Relation to Neuronal and Glial Changes Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4281 - 4287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Song, J. L. Barth, Y. Yu, K. Lu, A. Dashti, Y. Huang, C. K. Gittinger, W. S. Argraves, and T. J. Lyons Effects of Oxidized and Glycated LDL on Gene Expression in Human Retinal Capillary Pericytes Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2974 - 2982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Barber, D. A. Antonetti, T. S. Kern, C. E. N. Reiter, R. S. Soans, J. K. Krady, S. W. Levison, T. W. Gardner, and S. K. Bronson The Ins2Akita Mouse as a Model of Early Retinal Complications in Diabetes Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2210 - 2218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagai, K. Noda, T. Urano, Y. Kubota, H. Shinoda, T. Koto, K. Shinoda, M. Inoue, T. Shiomi, E. Ikeda, et al. Selective Suppression of Pathologic, but Not Physiologic, Retinal Neovascularization by Blocking the Angiotensin II Type 1 Receptor Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1078 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Izuora, H. P. Chase, W. E. Jackson, J. R. Coll, I. M. Osberg, P. A. Gottlieb, M. J. Rewers, and S. K. Garg Inflammatory Markers and Diabetic Retinopathy in Type 1 Diabetes Diabetes Care, March 1, 2005; 28(3): 714 - 715. [Full Text] [PDF]
|
|
|
|
|
|
I. G. Obrosova, P. Pacher, C. Szabo, Z. Zsengeller, H. Hirooka, M. J. Stevens, and M. A. Yorek Aldose Reductase Inhibition Counteracts Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase Activation in Tissue Sites for Diabetes Complications Diabetes, January 1, 2005; 54(1): 234 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zheng, C. Szabo, and T. S. Kern Poly(ADP-Ribose) Polymerase Is Involved in the Development of Diabetic Retinopathy via Regulation of Nuclear Factor-{kappa}B Diabetes, November 1, 2004; 53(11): 2960 - 2967. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
